Life Sciences

Harriet Fear CEO One Nucleus
Press Release: Partnerships built between Indian and UK life sciences, including stem cells

A major delegation of Indian life sciences companies spent several days in London and Leeds this week to explore investment and partnership opportunities. Nearly 20 Indian companies from the fields of regenerative medicine, biotechnology, oncology, medical technology and healthcare attended the bioConclave, the leading conference…

bioConclave
Press Release: Major delegation of Indian life sciences companies arrives in the UK, personalised chemotherapy collaboration announced

London, 10 May: Seeking to explore tie-ups in the UK’s life sciences sector, a major delegation of Indian life sciences and related companies are coming to London on 10th May, Over the last three years, the Indian life sciences market has grown by 12% per…

Professor Sir Malcolm Grant
A missed opportunity – Why is the UK not already a partner of choice for Indian companies in R&D, product development?

The UK and India share a long history of collaboration in research. Recent successes show that this relationship is further developing extremely positively. For example, the Newton Fund is a landmark collaboration between the UK Medical Research Council (MRC) and the Government of India Department for…

Harriet Fear
What’s trending in biotech India?

“What’s trending in biotech India?” That was the theme of Bangalore Bio this year, said to be the India’s leading biotechnology event, where it showcased the industries like Bio Pharma, Bio Agri and Bio Services. The answer is, quite a lot. The event was filled with most exciting…

AdobeStock_89476354_WM
Incredible press coverage for bioConclave, EPG initiative on life sciences

After the completion of the inaugural bioConclave in April 2015, an EPG initiative to bring European and Indian life sciences companies closer, with support from UK Trade & Investment, we had great feedback in the press. Below is a sample: The Guardian: Ed Miliband promises…

Pharma innovation
Can India become the hotspot for global innovation in pharma?

There has been a lot of discussion and speculation around whether or not India is capable of producing novel drug targets. Traditionally, the Indian pharmaceutical industry has stayed away from drug discovery or out-licensed molecules to large global companies in the early phase of development…

1

blog archive